KRAS and adenocarcinoma: Previous studies have shown that mutant K-ras expression in mice (using K-ras4bG12D, K-rasG12D or K-rasV12 alleles) is sufficient to initiate lung adenomas and adenocarcinomas 7, 9, 10, and pancreatic tumours 33 with few additional genetic or epigenetic alterations.